Search by Drug Name or NDC

    NDC 00407-2222-16 Visipaque 270 mg/mL Details

    Visipaque 270 mg/mL

    Visipaque is a INTRAVASCULAR INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GE Healthcare Inc.. The primary component is IODIXANOL.

    Product Information

    NDC 00407-2222
    Product ID 0407-2222_c2c4d356-1532-47f9-b142-d3a7300917c9
    Associated GPIs 94402041002025
    GCN Sequence Number 027418
    GCN Sequence Number Description iodixanol VIAL 270 MG/ML INTRAVEN
    HIC3 A6U
    HIC3 Description CARDIOVASCULAR DIAGNOSTICS-RADIOPAQUE
    GCN 46863
    HICL Sequence Number 011569
    HICL Sequence Number Description IODIXANOL
    Brand/Generic Brand
    Proprietary Name Visipaque
    Proprietary Name Suffix n/a
    Non-Proprietary Name Iodixanol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVASCULAR
    Active Ingredient Strength 270
    Active Ingredient Units mg/mL
    Substance Name IODIXANOL
    Labeler Name GE Healthcare Inc.
    Pharmaceutical Class Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020351
    Listing Certified Through 2024-12-31

    Package

    NDC 00407-2222-16 (00407222216)

    NDC Package Code 0407-2222-16
    Billing NDC 00407222216
    Package 10 BOTTLE, PLASTIC in 1 BOX (0407-2222-16) / 50 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2002-12-13
    NDC Exclude Flag N
    Pricing Information N/A